Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $801.1550 (1.13%) ($801.1550 - $801.1550) on Fri. Apr. 28, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.58% (three month average) | RSI | 38 | Latest Price | $801.1550(1.13%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | REGN declines -2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(49%) XLV(47%) DIA(35%) VYM(34%) IWD(33%) | Factors Impacting REGN price | REGN will decline at least -0.79% in a week (0% probabilities). VXX(-29%) VIXM(-22%) TBT(-4%) UUP(-3%) SHY(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.79% (StdDev 1.58%) | Hourly BBV | 1.2 () | Intraday Trend | 0% | | | |
|
Resistance Level | $810.96 | 5 Day Moving Average | $791.28(1.25%) | 10 Day Moving Average | $798.72(0.3%) | 20 Day Moving Average | $810.96(-1.21%) | To recent high | -3.5% | To recent low | 8.8% | Market Cap | $84.945b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |